| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/06/2001 | CA2410084A1 Transporters and ion channels |
| 12/06/2001 | CA2410033A1 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 12/06/2001 | CA2409597A1 Protein kinase inhibitors |
| 12/06/2001 | CA2409311A1 Regulators of apoptosis |
| 12/06/2001 | CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/06/2001 | CA2406979A1 Indole derivatives with vascular damaging activity |
| 12/05/2001 | EP1160319A2 Antisense-oligonucleotides for the treatment of immunosuppressive effects of transforming growth factor-beta (TGF-beta) |
| 12/05/2001 | EP1160254A1 Human vanilloid receptor-like proteins |
| 12/05/2001 | EP1160248A1 N-(Isoxazol-5-yl)-sulfonamide derivatives and their use as endothelin antagonists |
| 12/05/2001 | EP1160240A1 Guanylhydrazones for treating inflammatory conditions |
| 12/05/2001 | EP1159975A2 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159974A1 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159970A2 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss, comprising a nicotine receptor partial agonist and an anti-obesity agent |
| 12/05/2001 | EP1159962A1 Liposome preparations |
| 12/05/2001 | EP1159457A1 T cell receptor vbeta beta-jbeta) sequence and methods for its detection |
| 12/05/2001 | EP1159420A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
| 12/05/2001 | EP1159419A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 12/05/2001 | EP1159418A2 Muc-1 antagonists and methods of treating immune disorders |
| 12/05/2001 | EP1159417A2 Polynucleotides and proteins encoded thereby |
| 12/05/2001 | EP1159408A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 12/05/2001 | EP1159404A2 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 12/05/2001 | EP1159295A1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 12/05/2001 | EP1159292A2 Compounds having growth hormone releasing activity |
| 12/05/2001 | EP1159291A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 12/05/2001 | EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta |
| 12/05/2001 | EP1159284A1 33 human secreted proteins |
| 12/05/2001 | EP1159275A2 Imidazole compounds as histamine h3 ligands |
| 12/05/2001 | EP1159273A1 Compounds useful as reversible inhibitors of cathepsin s |
| 12/05/2001 | EP1159265A1 C-16 unsaturated fp-selective prostaglandins analogs |
| 12/05/2001 | EP1159264A2 INHIBITORS OF FACTOR Xa |
| 12/05/2001 | EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors |
| 12/05/2001 | EP1159006A2 Water-soluble compositions of bioactive lipophilic compounds |
| 12/05/2001 | EP1158998A1 Cardiac muscle function and manipulation |
| 12/05/2001 | EP1158997A2 Method of promoting myocyte proliferation and myocardial tissue repair |
| 12/05/2001 | EP1158984A1 Inhibitors of prenyl-protein transferase |
| 12/05/2001 | EP1158983A1 Inhibitors of prenyl-protein transferase |
| 12/05/2001 | EP1142903A9 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb 1? |
| 12/05/2001 | EP0971880B1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid |
| 12/05/2001 | EP0937036B1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 12/05/2001 | EP0855912B1 Nitrogen monoxide composition for use as a drug |
| 12/05/2001 | EP0835263B1 Somatostatin peptides |
| 12/05/2001 | EP0835244B1 Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors |
| 12/05/2001 | EP0814800B1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 12/05/2001 | EP0445255B2 USE OF HYALURONIC ACID IN COMBINATION WITH ASCORBIC ACID, ANTITUMOUR AGENTS AND/OR NSAIDs FOR TREATING CANCER |
| 12/05/2001 | CN1325534A Apparatus and method for brachytherapy |
| 12/05/2001 | CN1325452A Method for the preparation of quercetin and isoquercetin derivatives |
| 12/05/2001 | CN1325451A Recombinant adevovirus for tissue specific expression in heart |
| 12/05/2001 | CN1325408A Compounds with growth hormone releasing propenties |
| 12/05/2001 | CN1325407A Platelet-derived growth factor D, DNA coding therefor and uses thereof |
| 12/05/2001 | CN1325399A Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
| 12/05/2001 | CN1325393A Method for producing luteolin and luteolin derivatives |
| 12/05/2001 | CN1325390A 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/05/2001 | CN1325389A 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/05/2001 | CN1325384A Anthranilic acid amides and the use thereof as medicaments |
| 12/05/2001 | CN1325299A Orally administered controlled drug delivery system providing temporal and spatial control |
| 12/05/2001 | CN1324657A Chinese medicine prepn. for treating cardiac and cerebral vascular diseases and its prepn. process |
| 12/05/2001 | CN1324635A Brain benefiting pellet |
| 12/05/2001 | CN1324619A Health capsule of pure active chitosan and animal fiber |
| 12/05/2001 | CN1075836C Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 12/05/2001 | CN1075811C Substituted 2,4-thiazolindione derivative, its preparation method and medicinal composition containing same |
| 12/05/2001 | CN1075809C Novel vitamin D analogues |
| 12/05/2001 | CN1075732C Oral liquor for tonifying brain and reducing blood fat |
| 12/05/2001 | CN1075723C Medicine for treating angiocardiopathy |
| 12/04/2001 | US6326492 Heterocyclic protease inhibitors |
| 12/04/2001 | US6326476 Oxidation of bovine heparin using periodate, depolymerization, reduction, fractionation and accumulation |
| 12/04/2001 | US6326464 Genetically engineered tumor suppressor protein; for use in the treatment of cancers; antiproliferative agents |
| 12/04/2001 | US6326403 Cardiovascular disorders |
| 12/04/2001 | US6326398 Oxamic acids and derivatives as thyroid receptor ligands |
| 12/04/2001 | US6326378 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 12/04/2001 | US6326375 Containing an urea group |
| 12/04/2001 | US6326370 Use of agonists or antagonists of P2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 12/04/2001 | US6326359 Adenosine A2A receptor agonists as antiinflammatory agents |
| 12/04/2001 | US6326353 123therapy for septic shock; administering polymyxin by injection |
| 12/04/2001 | CA2214386C Optically active thiazolidinone derivatives |
| 12/04/2001 | CA2124763C Lipase inhibitor derived from a defatted rice germ |
| 12/02/2001 | CA2349388A1 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
| 12/01/2001 | CA2347276A1 I g e-dependent histamine-releasing factor (hrf) receptor, hrf-binding peptides and nucleic acids encoding the same, and uses thereof |
| 11/30/2001 | CA2348847A1 New isoxazole-sulfonamide endothelin antagonists |
| 11/29/2001 | WO2001090390A1 Use of baculovirus vectors in gene therapy |
| 11/29/2001 | WO2001090359A2 G-protein coupled receptors |
| 11/29/2001 | WO2001090334A2 Drug metabolizing enzymes |
| 11/29/2001 | WO2001090315A2 Production of neurons from stem cells |
| 11/29/2001 | WO2001090192A2 Bispecific immunoglobulin-like antigen binding proteins and method of production |
| 11/29/2001 | WO2001090189A2 G-protein coupled receptor org3. |
| 11/29/2001 | WO2001090186A1 Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof |
| 11/29/2001 | WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 11/29/2001 | WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses |
| 11/29/2001 | WO2001090148A2 Neurotransmitter transporters |
| 11/29/2001 | WO2001090142A2 FULL LENGTH HUMAN HCN1 Ih CHANNEL SUBUNIT AND VARIANTS |
| 11/29/2001 | WO2001090106A2 Tryasolyl tropane derivatives as ccr5 modulators |
| 11/29/2001 | WO2001090104A2 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 11/29/2001 | WO2001090103A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 11/29/2001 | WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 11/29/2001 | WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides |
| 11/29/2001 | WO2001090094A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/29/2001 | WO2001090093A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/29/2001 | WO2001090092A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/29/2001 | WO2001090091A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/29/2001 | WO2001090090A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/29/2001 | WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole |